3-(12,14-dioxo-10,13,16-triazahexacyclo[14.6.1.02,10.04,9.011,15.019,23]tricosa-1(22),4,6,8,11(15),17,19(23),20-octaen-13-yl)propyl N'-phenylcarbamimidothioate

InChIKey	`ZKGCHTUYVMLBSI-UHFFFAOYSA-N`
Compound Name	3-(12,14-dioxo-10,13,16-triazahexacyclo[14.6.1.02,10.04,9.011,15.019,23]tricosa-1(22),4,6,8,11(15),17,19(23),20-octaen-13-yl)propyl N'-phenylcarbamimidothioate
Canonical SMILES	`N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	N/A
Source	TTD_MultiTarget

2D Structure

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P06729	CD2	Homo sapiens	Human	PF05790 PF07686	Clinical	TTD_MultiTarget	TTD_MultiTarget
P11802	CDK4	Homo sapiens	Human	PF00069	Clinical	TTD_MultiTarget	TTD_MultiTarget
P24941	CDK2	Homo sapiens	Human	PF00069	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q02763	TEK	Homo sapiens	Human	PF00041 PF10430 PF07714	Clinical	TTD_MultiTarget	TTD_MultiTarget